You Might Also Like
View All Brochures
Mosaic Diagnostics and Galaxy Diagnostics Partner to Set a New Standard in Lyme and Coinfection Testing
OVERLAND PARK, KS. — June 2, 2025 — Today, Mosaic Diagnostics, the global pioneer in specialty diagnostic testing, announces the launch of a comprehensive Lyme + Co-Infections portfolio through a strategic partnership with Galaxy Diagnostics, a leader in advanced testing for flea and tick-borne pathogens.
As part of this partnership, Mosaic Diagnostics will now offer Galaxy’s full suite of diagnostic tests to its extensive network of integrative and functional medicine providers across the U.S.
Mycotoxin Induced Mitochondrial Dysfunction And Cytotoxicity
The following Q+A is a grouping of responses from Dr.
Beyond Symptoms: A Functional Medicine Approach to Chronic Disease
The material contained within this presentation is not intended to replace the services and/or medical advice of a licensed healthcare practitioner, nor is it meant to encourage diagnosis and treatment of disease.
Stay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.